David Tueller
Overview
Explore the profile of David Tueller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alaour B, Ferrari E, Heg D, Tueller D, Pilgrim T, Muller O, et al.
JACC Cardiovasc Interv
. 2024 Feb;
17(3):405-418.
PMID: 38355269
Background: Studies comparing long-term outcomes between non-vitamin K antagonist (VKA) oral anticoagulant agents (direct oral anticoagulant agents [DOACs]) and VKA anticoagulant agents after transcatheter aortic valve replacement (TAVR) are scarce,...
2.
Okuno T, Alaour B, Heg D, Tueller D, Pilgrim T, Muller O, et al.
JACC Cardiovasc Interv
. 2023 Dec;
16(24):2986-2996.
PMID: 38151313
Background: Stroke after transcatheter aortic valve replacement (TAVR) is associated with considerable morbidity and mortality. Predictors of stroke and the long-term risk after TAVR remain incompletely understood. Objectives: The authors...
3.
Attinger-Toller A, Ferrari E, Tueller D, Templin C, Muller O, Nietlispach F, et al.
JACC Cardiovasc Interv
. 2021 Apr;
14(9):952-960.
PMID: 33865734
Objectives: The aim of this study was to investigate age-related outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) as assessed in a nationwide, prospective, multicenter cohort study. Background: TAVR...
4.
Stortecky S, Heg D, Tueller D, Pilgrim T, Muller O, Noble S, et al.
J Am Coll Cardiol
. 2020 Jun;
75(24):3020-3030.
PMID: 32553254
Background: Infective endocarditis may affect patients after transcatheter aortic valve replacement (TAVR). Objectives: The purpose of this study was to provide detailed information on incidence rates, types of microorganisms, and...
5.
Ferrari E, Stortecky S, Heg D, Muller O, Nietlispach F, Tueller D, et al.
Eur J Cardiothorac Surg
. 2019 Jan;
56(1):55-63.
PMID: 30689870
Objectives: The SwissTAVI Registry includes all consecutive patients undergoing transcatheter aortic valve implantation (TAVI) and valve-in-valve (VinV) procedures for a failed bioprosthesis in Switzerland. We report the real world, all-comers,...
6.
Stortecky S, Franzone A, Heg D, Tueller D, Noble S, Pilgrim T, et al.
Eur Heart J Qual Care Clin Outcomes
. 2018 Oct;
5(3):242-251.
PMID: 30304513
Aims: To describe temporal trends in adoption and performance of transcatheter aortic valve implantation (TAVI) in Switzerland over a period of 5 years. Methods And Results: Between 2011 and 2015,...
7.
Stoller M, Gloekler S, Zbinden R, Tueller D, Eberli F, Windecker S, et al.
EuroIntervention
. 2018 Mar;
14(2):166-173.
PMID: 29553941
Aims: In this study we aimed to test the hypothesis that left ventricular (LV) afterload reduction in severe aortic valve stenosis (AS) by transcatheter aortic valve implantation (TAVI) acutely improves...
8.
Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes A, Tueller D, et al.
Circ Cardiovasc Interv
. 2017 Nov;
10(11).
PMID: 29127116
Background: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement. We sought to externally validate...
9.
Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, et al.
EuroIntervention
. 2017 Jan;
12(18):e2170-e2176.
PMID: 28067197
Aims: Data on procedural and clinical outcomes after transcatheter aortic valve implantation (TAVI) with the new-generation self-expanding Medtronic Evolut R prosthesis in comparison with its predecessor, the Medtronic CoreValve, are...
10.
Pilgrim T, Stortecky S, Nietlispach F, Heg D, Tueller D, Toggweiler S, et al.
J Am Heart Assoc
. 2016 Nov;
5(11).
PMID: 27856487
Background: The safety and effectiveness of the fully repositionable LOTUS valve system as compared with the balloon-expandable Edwards SAPIEN 3 prosthesis for the treatment of aortic stenosis has not been...